Warning: file_get_contents(https://r2.kuemeranti.store/public/mrdt/mar/elu/auth): Failed to open stream: HTTP request failed! HTTP/1.1 404 Not Found
in /home/tjsudsmac/public_html/index.php on line 2
TY - JOUR
AU - Gurisha, Mikidadi S.
AU - Kanaka Rao, Pulapa V.
AU - Cherupally, Laxmikanth
PY - 2024/12/02
Y2 - 2025/08/01
TI - Inhibitory Activities of Phytoconstituents from Azadirachta indica and Murraya koenigii as Potential Drugs for Secondary Infection of Atopic Eczema Disease - In silico study
JF - Tanzania Journal of Science
JA - Tanz. J. Sci.
VL - 50
IS - 4
SE - Biological Sciences
DO - 10.4314/tjs.v50i4.3
UR - https://tjs.udsm.ac.tz/index.php/tjs/article/view/2192
SP - 737-754
AB - <p class="western" align="justify"><span style="font-family: Times New Roman, serif;"><span style="font-size: small;">Atopic Eczema (AE) disease is a chronic inflammatory skin condition that is caused by a person’s inability to repair damage to the skin barrier. </span></span><span style="font-family: Times New Roman, serif;"><span style="font-size: small;"><em>Staphylococcus aureus </em></span></span><span style="font-family: Times New Roman, serif;"><span style="font-size: small;">(SA</span></span><span style="font-family: Times New Roman, serif;"><span style="font-size: small;"><em>)</em></span></span><span style="font-family: Times New Roman, serif;"><span style="font-size: small;"> is a virulent pathogen that plays an important role in the progression of secondary infection in AE patients, thus intensifying the disease's virulence. In this study, the inhibitory activities of phytoconstituents from </span></span><span style="font-family: Times New Roman, serif;"><span style="font-size: small;"><em>Azadirachta indica</em></span></span><span style="font-family: Times New Roman, serif;"><span style="font-size: small;"> and </span></span><span style="font-family: Times New Roman, serif;"><span style="font-size: small;"><em>Murraya koenigii</em></span></span><span style="font-family: Times New Roman, serif;"><span style="font-size: small;"> against the SA (Protein Data Bank ID: 7TIO) using an </span></span><span style="font-family: Times New Roman, serif;"><span style="font-size: small;"><em>in silico</em></span></span><span style="font-family: Times New Roman, serif;"><span style="font-size: small;"> approach are presented. Site-specific docking analysis was carried out on the virulent pathogen with the docking center at X: 1.65044, Y: 1.7980, Z: 3.1878, for a box of dimension X: 64.2332, Y: 40.2828, Z: 41.8202. The natural compounds were chosen based on their absorption, distribution, metabolism, excretion, and toxicity characteristics, as well as other drug-like characteristics computed in Swiss ADME and pkCSM software. Four compounds, Gedunin (-7.2 kCal/mol), Curryanine (-7.1 kCal/mol), Mahanimbinine (-6.6 kCal/mol) and Mahanine (-6.5 kCal/mol) with good inhibition for the </span></span><span style="font-family: Times New Roman, serif;"><span style="font-size: small;"><em>S. aureus</em></span></span><span style="font-family: Times New Roman, serif;"><span style="font-size: small;"> pathogen were discovered to exhibit better docking scores compared to Prednisone (-6.1 kcal/mol) (control drug). The studied Phytoconstituents of </span></span><span style="font-family: Times New Roman, serif;"><span style="font-size: small;"><em>A. indica</em></span></span><span style="font-family: Times New Roman, serif;"><span style="font-size: small;"> and </span></span><span style="font-family: Times New Roman, serif;"><span style="font-size: small;"><em>M. koennigii</em></span></span><span style="font-family: Times New Roman, serif;"><span style="font-size: small;"> thus can be used as inhibitors of SA pathogen (7TIO) in the fight against AE disease. </span></span></p>
ER -